Forte Biosciences’ $25 Million Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati represented Forte Biosciences in the transaction.Forte Biosciences (NASDAQ: FBRX) announced key R&D updates for its product candidate FB-102 (a proprietary molecule with…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here